Swedish snus use is associated with mortality: a pooled analysis of eight prospective studies
Marja Lisa Byhamre, Marzieh Araghi, Lars Alfredsson, Rino Bellocco, Gunnar Engström, Marie Eriksson, Maria Rosaria Galanti, Jan‐Håkan Jansson, Anton Lager, Michael Lundberg, Per‐Olof Östergren, Nancy L. Pedersen, Ylva Trolle Lagerros, Weimin Ye, Patrik Wennberg, Cecilia Magnusson
Abstract
BACKGROUND: The health consequences of the use of Swedish snus, including its relationship with mortality, have not been fully established. We investigated the relationship between snus use and all-cause and cause-specific mortality (death due to cardiovascular diseases, cancer diseases and all other reasons, respectively) in a nationwide collaborative pooling project. METHODS: We followed 169 103 never-smoking men from eight Swedish cohort studies, recruited in 1978-2010. Shared frailty models with random effects at the study level were used in order to estimate adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) of mortality associated with snus use. RESULTS: Exclusive current snus users had an increased risk of all-cause mortality (aHR 1.28, 95% CI 1.20-1.35), cardiovascular mortality (aHR 1.27, 95% CI 1.15-1.41) and other cause mortality (aHR 1.37, 95% CI 1.24-1.52) compared with never-users of tobacco. The risk of cancer mortality was also increased (aHR 1.12, 95% CI 1.00-1.26). These mortality risks increased with duration of snus use, but not with weekly amount. CONCLUSIONS: Snus use among men is associated with increased all-cause mortality, cardiovascular mortality, with death from other causes and possibly with increased cancer mortality.